Health Care
Every Health Care company, ranked against its own size class — small, mid, and large cap, side by side.
Small-cap$300M–2B186 members
- 1ZVRA⚠ZEVRA THERAPEUTICS, INC.99$826M
- 2CRMD⚠CorMedix Inc.99$686M
- 3LKFT⚠Lakefront Biotherapeutics NV99$2.0B
- 4ABUSArbutus Biopharma Corp98$962M
- 5TBPHTheravance Biopharma, Inc.98$877M
- 6RIGLRIGEL PHARMACEUTICALS INC97$716M
- 7XOMAXOMA Royalty Corp97$760M
- 8SRTAStrata Critical Medical, Inc.96$468M
- 9ANIPANI PHARMACEUTICALS INC95$2.0B
- 10DCTHDELCATH SYSTEMS, INC.95$456M
- 11ASMBASSEMBLY BIOSCIENCES, INC.94$550M
- 12ETONEton Pharmaceuticals, Inc.93$1.0B
- 13ANABANAPTYSBIO, INC93$1.9B
- 14XERSXeris Biopharma Holdings, Inc.93$1.4B
- 15BWAYBrainsway Ltd.92$610M
Mid-cap$2–10B120 members
- 1TGTXTG THERAPEUTICS, INC.99$8.2B
- 2LQDA⚠Liquidia Corp99$7.0B
- 3LGNDLIGAND PHARMACEUTICALS INC98$6.4B
- 4BLLNBillionToOne, Inc.97$5.5B
- 5CHECHEMED CORP96$6.5B
- 6TMDXTransMedics Group, Inc.95$2.4B
- 7HALOHALOZYME THERAPEUTICS, INC.95$9.4B
- 8KNSAKiniksa Pharmaceuticals International, plc94$5.0B
- 9CAICaris Life Sciences, Inc.93$5.2B
- 10AUPHAurinia Pharmaceuticals Inc.92$2.0B
- 11ARQTArcutis Biotherapeutics, Inc.91$3.2B
- 12HIMSHims & Hers Health, Inc.90$8.5B
- 13CPRXCATALYST PHARMACEUTICALS, INC.90$3.9B
- 14TVTXTravere Therapeutics, Inc.89$5.3B
- 15ADMAADMA BIOLOGICS, INC.88$2.1B
Large-cap$10B+104 members
- 1LLYELI LILLY & Co99$1.1T
- 2KRYSKrystal Biotech, Inc.99$11.1B
- 3ALNYALNYLAM PHARMACEUTICALS, INC.98$41.8B
- 4ISRGINTUITIVE SURGICAL INC97$150.9B
- 5INCYINCYTE CORP96$23.3B
- 6NBIXNEUROCRINE BIOSCIENCES INC95$17.5B
- 7PODDINSULET CORP94$11.4B
- 8ONCBeOne Medicines Ltd.93$30.9B
- 9GMABGENMAB A/S92$17.5B
- 10MDGL⚠MADRIGAL PHARMACEUTICALS, INC.91$12.2B
- 11BSXBOSTON SCIENTIFIC CORP88$67.1B
- 12ARWR⚠ARROWHEAD PHARMACEUTICALS, INC.88$11.8B
- 13MEDPMedpace Holdings, Inc.88$15.9B
- 14GMEDGLOBUS MEDICAL INC87$10.9B
- 15PENPenumbra Inc86$12.5B
Ranked by percentile within each size class (60% revenue growth, 40% net margin) — 99 is best in the class, not best in the market, so a fast, profitable mid-size name can outrank a mega-cap. ⚠ marks extreme growth off a small revenue base. Click any company for its full profile.